(For treatment side effects and complications only)
The Clatterbridge Cancer Centre (CCC) has long recognised the importance of patient and public participation in routine and research activities. Patients are invited to participate in clinical trials.
In 2014, NHS England published its Five Year Forward View which proposed a more engaged relationship with patients and carers. For compliance, our directorate of Research & Innovation has sought to extend patients’ involvement in its activities.
In 2019-2020, CCC launched a comprehensive Patient Involvement Strategy to ensure that our care and services take into account patient and public experience.
In addition, CCC is committed to involving diverse socio-economic groups of patients and public in its research activities. Such involvement provides a wealth of insight, perspectives, expertise and experience.
In November 2020, our newly established Patient and Public Involvement Forum convened for the first time. It meets on a regular basis and, in November 2021, a quarterly newsletter from the Forum was launched.
Emma Whitby, Head of Research Delivery, said: “I’m delighted with the formation of the PPI group. Patients are at the heart of what we do and ensuring they have a voice that is heard is of paramount importance to staff in R&I.”
For more information about the Forum or to ask to join it, please contact Mary Jordan, R&I Project Support Manager, via email on email@example.com
You can read the newsletters by clicking the links below.